Medication to Induce Withdrawal Bleeding in Secondary Amenorrhea (16-Year-Old)
For a 16-year-old with secondary amenorrhea, use oral medroxyprogesterone acetate (MPA) 5-10 mg daily for 5-10 days OR micronized progesterone 200-300 mg daily for 10 days to induce withdrawal bleeding 1.
Progestin Challenge: First-Line Approach
The progestin challenge test serves dual purposes: it induces withdrawal bleeding AND provides diagnostic information about the patient's estrogen status. If withdrawal bleeding occurs after progestin administration, this confirms adequate endogenous estrogen levels and a patent outflow tract 1.
Specific Regimen Options:
- Medroxyprogesterone acetate (MPA): 5-10 mg daily for 5-10 days 1
- Norethindrone acetate: 5 mg daily for 5-10 days 1
- Micronized progesterone: 200-300 mg daily for 10 days 1
Practical Implementation:
Some patients tolerate progestins poorly. Start with a shorter 5-day course and repeat in a few weeks if no withdrawal bleed occurs 1. This approach balances efficacy with tolerability in adolescents.
Alternative: Combined Hormonal Contraceptives
If contraception is needed or desired, combined oral contraceptives (COCs) can be used instead, which will induce withdrawal bleeding during the hormone-free interval 2. COCs can be started at any time if pregnancy is reasonably excluded 2.
For adolescents specifically, low-dose COCs or short-term estrogen (10-20 days) can induce bleeding 2, though this is typically reserved for managing irregular bleeding patterns rather than as first-line for amenorrhea.
When Progestin Fails
Absence of withdrawal bleeding after progestin indicates either outflow tract obstruction OR insufficient endometrial estrogen exposure 1. In this scenario:
- Perform pelvic ultrasound to assess endometrial thickness and Müllerian tract integrity 1
- Consider MRI if structural abnormalities are suspected 1
- If estrogen deficiency is confirmed, sequential estrogen-progestin therapy becomes necessary rather than progestin alone
Important Caveats
Always exclude pregnancy before initiating any hormonal therapy 2. This is non-negotiable in any adolescent with amenorrhea.
The progestin challenge is diagnostic as well as therapeutic—it differentiates between anovulation with adequate estrogen (will bleed) versus hypothalamic amenorrhea or ovarian failure (may not bleed) 1, 3. This distinction fundamentally changes management.
Do not use progestin-only therapy long-term without addressing the underlying cause of amenorrhea. While it induces withdrawal bleeding, it doesn't treat conditions like functional hypothalamic amenorrhea, which requires addressing energy deficit, stress, or excessive exercise 1.
For adolescents with confirmed hypoestrogenic states (no withdrawal bleed after progestin), hormone replacement therapy with transdermal 17β-estradiol plus cyclic progestin is preferred over COCs to support bone health and pubertal development 4. However, this applies to specific conditions like premature ovarian insufficiency, not typical secondary amenorrhea.